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Abstract
Nitric oxide (NO) plays an important role as a cell-signalling molecule, anti-infective agent and, as most recently
recognised, an antioxidant. The metabolic fate of NO gives rise to a further series of compounds, collectively known as the
reactive nitrogen species (RNS), which possess their own unique characteristics. In this review we discuss this emerging aspect
of the NO field in the context of the formation of the RNS and what is known about their effects on biological systems. While
much of the insight into the RNS has been gained from the extensive chemical characterisation of these species, to reveal
biological consequences this approach must be complemented by direct measures of physiological function. Although we do
not know the consequences of many of the dominant chemical reactions of RNS an intriguing aspect is now emerging. This
review will illustrate how, when specificity and amplification through cell signalling mechanisms are taken into account, the
less significant reactions, in terms of yield or rates, can explain many of the biological responses of exposure of cells or
physiological systems to RNS. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
The intensive research surrounding nitric oxide
(NO) and its metabolites has given rise to a new
term, the ‘reactive nitrogen species’ (RNS), in the
biological literature [1^3]. By strict chemical criteria
‘RNS’ encompasses such a diverse range of com-
pounds, with contrasting and distinct properties,
that their only unifying characteristic can be deriva-
tion from NO. However, recent advances are giving
important insights into the biology and biochemistry
of speci¢c RNS, their e¡ects on normal physiology
and potential contribution to disease. An aspect we
will dissect here are the reactions with other free
radicals or oxygen to generate the RNS and their
biological e¡ects (Fig. 1).
Intense investigation over the last 10 years has led
to a rapid change in the general concepts relating to
free radical biochemistry. It is now clear that free
radicals are not necessarily short lived and reactive,
but like any other class of compounds exhibit a
broad range of chemical and physical properties.
Likewise their biological properties are not always
deleterious. An interesting and topical example is
nitric oxide, which is relatively speci¢c in its e¡ects,
not very reactive and serves important physiological
functions. Like reactive oxygen species (ROS), RNS
are derived from the interactions of biologically gen-
erated free radicals to form more persistent species
resulting in multiple biological e¡ects.
Nitric oxide is formed by a family of enzymes, and
directly serves signalling functions in the cell. Nitric
oxide plays an essential part of normal physiology,
discussed in detail in the other articles in this issue,
and is a potential route to the pathophysiology asso-
ciated with a number of diseases. From one perspec-
tive the most signi¢cant reactions of RNS are those
which occur with the highest yield. However, since
cells have the capacity to amplify signals and select
speci¢c chemical species, then the reactions of RNS
of most physiological or pathological signi¢cance can
only be determined by examining their e¡ects in a
biological system. Reactions of NO ultimately lead
to the oxidation, nitration (addition of NO2), nitro-
sation (addition of NO), nitrosylation (NO) of most
classes of biomolecules. One of the best known inter-
actions of NO leading to cell signalling is the rever-
sible covalent binding, nitrosylation, with the ferrous
haem in soluble guanylate cyclase. This aspect of NO
signalling will be discussed in detail in other articles
in this volume. Here we will discuss the reactions of
RNS derived from NO with proteins, lipids and car-
bohydrates.
2. Formation of reactive nitrogen species in biological
systems
In biological systems the primary source of all
RNS is NO (Fig. 1). The biochemistry of NO for-
mation has been discussed in depth in this issue but a
key factor relevant to this discussion is the range of
concentrations of NO (20 nM^2 WM) generated by
the nitric oxide synthases (NOS) [1,2]. However, this
factor places some constraints on the mechanisms of
RNS formation since the maximal activation of these
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enzymes is unlikely to yield steady state concentra-
tions of NO higher than 1^2 WM in the cytosolic
compartment. The most prominent NO reactions
which occur at these relatively low concentrations
are with the transition metal centres, iron and cop-
per, in proteins or reactions with other free radicals
and oxygen. The reactions of NO with iron centres
are well established but that with copper containing
proteins is still emerging. One of the most signi¢cant
in biological terms is likely to be the reaction of NO
with the copper in the oxygen binding site of cyto-
chrome c oxidase (fully discussed in an accompany-
ing article).
The rapid reactions of NO with free radicals has
emerged as one of the major routes to the formation
of RNS and, at present, the best understood of these
is the reaction with superoxide (O32 ) to form peroxy-
nitrite (ONOO3) [4,5]. Peroxynitrite is chemically
unstable under physiological conditions resulting in
the formation of nitrate through isomerisation. Since
nitrate is essentially biochemically inert in mamma-
lian cells then this reaction was viewed as an excel-
lent method to scavenge and neutralise O32 [6]. As
studies on this interaction progressed a new perspec-
tive emerged as it was realised that ONOO3 is reac-
tive with all the major classes of biomolecules and,
therefore, has the potential to mediate cytotoxicity
independently of NO or O32 [4].
While the sources of NO are mostly restricted to
the NOS isozymes other metabolic pathways, involv-
ing nitrite, are now emerging, particularly under
acidic or ischaemic conditions, as discussed in the
accompanying article by Dr. J. Zweier. The produc-
tion of O32 appears to arise from diverse candidates
that give variable and poorly de¢ned rates of O32
production [7] (Fig. 1). Under some circumstances,
such as exposure to high concentrations of lipopro-
teins or in the presence of redox cycling xenobiotics,
the electron transfer between NAD(P)H in NOS and
arginine becomes ‘uncoupled’ resulting in the accel-
erated formation of O32 [8]. This has led to the pro-
vocative idea that in these situations NOS can serve
as an ONOO3 synthase [9]. Peroxynitrite can medi-
ate one electron transfer reactions that produce a
free radical species. In a lipid this can result in ini-
tiation of a self-sustaining peroxidation reaction
[10,11]. Peroxynitrite-dependent two electron oxida-
tions can modify molecules with aromatic structures
such as the important antioxidant K-tocopherol [11].
In this case a free radical is not formed from either
ONOO3 or the reactant.
It was demonstrated early on that ONOO3 can
react with both low molecular weight and protein
bound thiols [12^15]. This results in formation of
thiyl radicals and leads to thiol oxidation. Based on
the high intracellular concentrations of thiols it has
been argued that the reaction between ONOO3 and
glutathione represents a major protection mechanism
against ONOO3-dependent oxidative injury [13],
although under some circumstances thiols can exac-
erbate damage [16]. Furthermore, this reaction also
results in the formation of S-nitrosoglutathione, an
NO donating molecule, and together with modi¢ca-
tion of the redox status of the cell could have im-
portant implications in a variety of cell signalling
pathways [17^19]. While this reaction occurs at a
low yield the intracellular metabolic release of NO
Fig. 1. Nitric oxide-dependent reactions that lead to the forma-
tion of RNS. Through the rapid reaction of NO and O32 , per-
oxynitrite (ONOOH) is formed and leads to oxidation, nitrosa-
tion (addition of NO) or nitration (addition of NO2). Nitric
oxide is formed from the enzymatic action of the nitric oxide
synthases (NOS) which under some circumstances can also pro-
duce O32 . There are further potential sources of O
3
2 in the cell
including xanthine oxidase (XOD), NAD(P)H oxidases
(NAD(P)H ox and respiratory complexes within the mitochon-
dria (Mito). Recently it has also been shown that the enzyme
myeloperoxidase (MPO) can cause nitration reactions using ni-
trite (NO32 ) and its product hypochlorite (HOCl) as a substrate.
The oxidation reactions (e.g. oxidation of glutathione) occur at
the highest chemical yield but the nitration (e.g. formation of
nitrotyrosine) or nitrosation (e.g. formation of S-nitrosogluta-
thione) reactions are also biologically signi¢cant since they can
alter cell signalling and generate NO donors.
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is likely to be cytoprotective through both its func-
tions as a cell signalling molecule and antioxidant.
Nitrosation and nitration reactions produce chemi-
cally stable derivatives and are able to elicit biolog-
ical e¡ects distinct from their progenitors. Initially, it
was thought that the stable nitration of tyrosine was
unique to ONOO3 and therefore a marker for its
formation [20]. Nitrotyrosine antibodies have been
important investigative tools in determining the role
of nitration reactions in NO-dependent pathophysi-
ology [21^26]. However, more recent studies have
shown that the enzyme myeloperoxidase (MPO)
can, under some circumstances, induce nitration of
tyrosine. Since nitrotyrosine formation is often asso-
ciated with in£ammation, this is an important aspect
that will also be discussed.
3. Reactive nitrogen species in membranes and
lipoproteins
The reaction of NO with oxygen is emerging as a
possible event in the lipophilic domain of membranes
and lipoproteins. Furthermore, the reactions of NO
are substantially modi¢ed by the presence of the
chain propagating lipid peroxyl radicals during lipid
peroxidation. First we discuss the reactions of NO in
a biological membrane in which peroxidation is ab-
sent and the dominant reactions are those with oxy-
gen. We will then consider how NO behaves in a
system populated with propagating lipid peroxyl rad-
icals.
Since the rate of reaction of oxygen and NO is
proportional to both oxygen and the square of the
NO concentration, it has been argued that this reac-
tion is too slow to contribute to NO metabolism in
an aqueous compartment [27]. However, this situa-
tion changes in membranes and lipoproteins with an
estimated 10-fold increase in the oxygen-dependent
consumption of NO [28]. This increase in rate is di-
rectly attributable to the 8^10-fold higher solubility
of NO in the hydrophobic phase of the lipid mem-
branes. Taking into account the relative volume of
the cytosol and membrane structures in a cell, it was
estimated that the velocity of the reaction of NO
with oxygen is 300 times greater in the hydrophobic
environment [28]. It would follow that this should
result in higher yields of intermediates, including di-
nitrogen trioxide (N2O3), dinitrogen tetroxide (N2O4)
and the free radical nitrogen dioxide (NO2) [29].
While NO2 is an initiator of lipid oxidation [30],
exposure of lipids to NO alone does not result in
lipid peroxidation [31]. As discussed elsewhere in
this issue, NO itself inhibits lipid oxidation induced
by a variety of oxidants [31^33]. An explanation for
this phenomenon is the facile scavenging of lipid per-
oxyl radicals (LOO) by NO [34], thus preventing sig-
ni¢cant accumulation of products of chain propaga-
tion (Fig. 2).
The reaction of NO with peroxyl radicals is a fur-
ther route to lipid derived RNS. Nitric oxide inhibits
oxidative modi¢cation of low-density lipoprotein
(LDL), model lipid systems and attenuates the con-
sequent formation of secondary products of lipid ox-
idation [31^33]. In comparison to other antioxidants,
such as K-tocopherol, NO is extremely e⁄cient even
though two NO molecules are consumed for each
peroxyl radical [33]. This can be explained on the
basis of the rapid rate of the initial termination re-
action of NO with peroxyl radicals and because NO
concentrates in lipophilic environments. The termi-
nation reaction between NO and LOO will also yield
a transient organic ONOO3 intermediate (LOONO).
These species are unstable and will rearrange by cage
recombination of the alkoxyl/NO2 radical pair to
give primarily an organic nitrate (LONO2), di¡use
apart to yield alkoxyl/epoxyallylic lipid radical spe-
cies and NO2, or hydrolyse to give a lipid alkoxide
and nitrite (NO32 ) [35]. However, in the presence of
NO, the decomposition products are themselves ter-
Fig. 2. Reactions of NO within hydrophobic compartments.
Higher concentrations of NO within hydrophobic compartments
may result in its reaction with oxygen forming a variety of in-
termediates (e.g. NO2) capable of initiating lipid peroxidation
reactions which are propagated by lipid peroxyl radicals (LOO).
Oxidative damage to lipids mediated by NO2 or other oxidant
species may be prevented, however, by termination of propagat-
ing peroxyl radicals (LOO) by NO.
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minated, thus resulting in an overall inhibition of
lipid peroxidation [33]. Since in membranes and lipo-
proteins the main source of lipid oxidation products
come from propagation reactions, then NO is an
antioxidant in this context. The subsequent biologi-
cal fate of nitrated lipids may impact on this inter-
pretation and is a focus of further study of this class
of RNS.
The nitration of lipids has also been detected, both
as potential by-products of NO-dependent inhibition
of lipid peroxidation and the direct reaction of lipid
hydroperoxides with RNS. The precise mechanisms
involved are still being de¢ned. Exposure of lipid
peroxidation systems to continuous £uxes of NO
and O32 can result in the formation of these species
and recent data suggests that acidi¢ed NO32 will also
react with lipid peroxides to form stable nitrated
products (unpublished results).
The oxidising potential of ONOO3 is su⁄cient
that it can directly initiate lipid peroxidation reac-
tions by abstracting a hydrogen atom from a poly-
unsaturated fatty acid and also results in the forma-
tion of nitrated lipids [9,10,31]. This has been
demonstrated in both model lipid systems and LDL
[9,10,36^38]. The lipoproteins are particularly inter-
esting as they contain a mixture of targets for
ONOO3 including amino acids, antioxidants and un-
saturated lipids, and, furthermore, oxidative damage
to LDL is an important aspect step during athero-
genesis [39].
In summary, the reaction between RNS and fatty
acids can result in the formation of both oxidised
lipids as well as nitrated lipid species. The latter de-
rivatives may possess both unique reactivities or have
similar e¡ects to oxidised lipids. Since biological sys-
tems can be exquisitely sensitive to receptor mediated
e¡ects this is likely to be a productive area for elu-
cidating the e¡ects of lipid based RNS. For example,
nitrated lipids could elicit cellular responses by acting
as agonists for eicosanoid-like G protein-coupled re-
ceptors, or by acting as mediators of signal trans-
duction [40].
4. Scavenging peroxynitrite reaction with metals
In biological systems peroxides (e.g. hydrogen per-
oxide and lipid hydroperoxides) are detoxi¢ed by
metalloproteins. Initial studies on the reaction be-
tween ONOO3 and haem proteins showed that
ONOO3 can oxidise myeloperoxidase and lactoper-
oxidase forming a haem oxidation intermediate
called compound II [41]. In this reaction the ground
state of the enzyme (containing iron in the ferric i.e.
Fe3 form), is oxidised to the ferryl form (the iron
oxidation state being Fe4). This study also demon-
strated that ONOO3 can also mediate two electron
transfer processes as the reaction with horseradish
peroxidase resulted with the initial formation of com-
pound I (i.e. the ferryl oxidation state with an asso-
ciated protein based or porphyrin based cation rad-
ical). Furthermore, these reactions are all mediated
by peroxynitrous acid, are rapid and similar to
changes seen with the classical substrate for these
enzymes, hydrogen peroxide. However, it is not
known whether reaction with ONOO3 led to enzyme
inactivation. It has been reported that in the presence
of a peroxide substrate, peroxidases through the for-
mation of compounds I and II mediate oxidative
damage to biological molecules [42]. The formation
of these oxidation states in haem proteins by
ONOO3 could therefore provide an alternate, and
potential ampli¢cation mechanism of oxidative dam-
age.
Peroxynitrite also reacts with haemoglobin. Simi-
lar to hydrogen peroxide, addition of ONOO3 to
oxyhaemoglobin (i.e. where the iron is in the physio-
logical ferrous oxidation state) resulted in oxidation
of the haem and formation of methaemoglobin (i.e.
ferric) [43,44]. More recently, it was shown that ex-
posure of red blood cells to ONOO3 also resulted in
the formation of methaemoglobin indicating that re-
action with haem proteins, in this system at least, can
compete with alternative targets for ONOO3 e.g.
glutathione [45].
In vitro studies also showed that ONOO3 can ni-
trate haemoglobin [44], and when high concentra-
tions were added to red blood cells covalent modi¢-
cation of membrane proteins occurred [46,47]. It was
demonstrated that ONOO3 could di¡use through
the anion exchange channel and across the red blood
cell membrane [45]. This latter property was also
shown in liposomal systems investigating the reaction
between model porphyrin compounds, containing
manganese or iron as the redox active metal centre,
with ONOO3 [48]. These data led the authors to
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suggest that liposome encapsulated porphyrinic com-
pounds may be an e⁄cient strategy to protect against
ONOO3 related oxidative damage [49]. Thus,
although ONOO3 has a relatively short half-life
under physiological conditions, its rate of di¡usion
across biological membranes is su⁄ciently rapid such
that reactions at distant sites of its formation can
occur.
The relatively high reactivity of ONOO3 has made
the development of speci¢c scavengers di⁄cult.
Based on kinetic grounds, however, metal containing
compounds are the most promising candidates. Re-
cently, the role of selenium compounds as potential
peroxynitrite scavengers were reported [50]. It was
shown that the enzyme glutathione peroxidase which
contains a selenocysteine moiety in its active site,
rapidly reduces peroxynitrite to nitrite and protects
against formation of 3-nitrotyrosine [51]. The classi-
cal view of this peroxidase enzyme is that it catalyses
the glutathione-dependent reduction of hydrogen
peroxide and lipid hydroperoxides and thus repre-
sents an important antioxidant defence mechanism.
On the basis of these ¢ndings ONOO3 should also
be added to this list. It should be noted that although
a reaction between the reduced form of glutathione
peroxidase and ONOO3 does not e¡ect enzyme ac-
tivity [51], reaction of ONOO3 with the oxidised
enzyme leads to inhibition [52]. Synthetic analogs
of glutathione peroxidase (e.g. ebselen) have been
shown to also possess a ‘peroxynitrite reductase’ ac-
tivity, and protect against ONOO3 mediated oxida-
tion and nitration reactions [53,54]. The relatively
high rates of reaction of ONOO3 with metal con-
taining compounds suggests that they may make use-
ful ONOO3 scavengers, and are indeed being cur-
rently evaluated as such. These studies also
demonstrate that ONOO3 can rapidly react with
non-haem metal containing proteins. Other examples
include the reaction between ONOO3 and copper
containing proteins such as superoxide dismutase
and caeruloplasmin. In the former case this results
in the formation of a species capable of nitrating
phenolics, and in the latter copper is released from
the protein [20,55].
Recent studies suggest that reactions between
ONOO3 and haem proteins may have physiological
functions. The enzyme prostaglandin synthase catal-
yses the production of prostaglandins and thrombox-
anes, both important mediators of in£ammation and
other processes [56]. Peroxynitrite was found to be
an excellent substrate for the enzyme peroxidase ac-
tivity, thereby stimulating cyclooxygenase activity
and the subsequent formation of prostaglandins
[57]. Furthermore, prostaglandin biosynthesis in
macrophages was inhibited by superoxide dismutase
mimetics, indicating that this may be a mechanism
by which ONOO3 can be linked to pro-in£amma-
tory reactions in vivo. As yet, no other peroxidase
enzymes have been identi¢ed in which ONOO3 can
act as a substrate, but this remains an intriguing
possibility. It is worth mentioning that while
ONOO3 can clearly oxidise numerous haem com-
pounds, this is not the case for all metal containing
proteins. For example guanylate cyclase catalyses the
nitric oxide mediated formation of cyclic guanosine
monophosphate [58]. Similar to haemoglobin this
contains an iron containing haem group in its active
site, but is not oxidised by ONOO3 [59].
Interestingly, ONOO3 can also inactivate haem
proteins. For example all the NOS isoforms were
irreversibly inhibited by ONOO3, with IC50 values
between 10 and 20 WM [60]. The mechanism of in-
activation was suggested to be oxidation and subse-
quent destruction of the haem-thiolate catalytic
centre. It should be noted, however, that this mech-
anism does not operate for all haem-thiolate enzymes
as thromboxane synthase was una¡ected by
ONOO3, whereas the structurally similar prostacy-
clin synthase was inhibited, although this mode of
inactivation was due to tyrosine nitration [61]. Dis-
ruption of iron-sulphur centres by ONOO3 can also
lead to inactivation of enzymes such as aconitase
[62^64], thereby linking RNS to alterations in mito-
chondrial function.
5. Nitration at sites of in£ammation
Cells that are recruited to sites of injury and ini-
tiate in£ammatory events such as macrophages and
activated neutrophils, produce relatively high con-
centrations of NO (via the inducible isoform of
NOS). It has been suggested that this leads to an
increase in the formation of ONOO3 which is then
used as part of the arsenal against invading patho-
gens [65]. Although this is an important host defence
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system, similar reactions, as evidenced by the detec-
tion of nitrotyrosine, appear to occur during the de-
velopment of various pro-in£ammatory diseases such
as atherosclerosis and rheumatoid arthritis [24^26],
and this has led to the hypothesis that ONOO3 is
an important mediator of such pathologies. Nitration
reactions mediated by ONOO3 are ine⁄cient relative
to oxidation reactions. More recently, however, it
was shown that at physiological concentrations of
carbon dioxide, the reactivity of ONOO3 is shifted
towards nitration [66^69]. This has been hypothes-
ised to occur via the formation of the intermediate
nitrosoperoxycarbonate (ONOOCOO3) [70].
A recent study has shown that the in vitro nitra-
tion of tyrosine in aqueous solution is approx. 4%,
following bolus addition of ONOO3, with yields fall-
ing to approx. 0.07% from ONOO3 produced by the
simultaneous generation of NO and O32 [71]. This
presents a problem for the hypothesis that 3-nitro-
tyrosine in biological systems is a product of
ONOO3, since the only currently recognised biolog-
ically relevant source of ONOO3 is through the re-
action of NO and O32 . At ¢rst glance, this observa-
tion may underscore the idea that other mechanisms
contribute to tyrosine nitration in vivo. These alter-
native mechanisms are, no doubt, signi¢cant and will
be discussed in more detail later.
However, there are a number of factors that need
to be taken into account before the role of ONOO3
in tyrosine nitration in a biological or pathological
setting is ruled out. (1) The fact that the yields from
nitration of tyrosine from the co-generation of NO
and O32 are low is not, a priori, critical since nitrated
proteins may accumulate over many days, or even
weeks, if the turnover or metabolism of the modi¢ed
protein is also low. It thus becomes important to
understand the relative e⁄ciency of the di¡erent
mechanisms leading to tyrosine nitration. (2) Nitra-
tion of free tyrosine in an aqueous milieu does not
take into account that the reactions in a biological
setting may be promoted through the adventitious
binding of transition metals close to tyrosine resi-
dues. In fact, not all tyrosines in a protein are
equally susceptible to nitration, for example neigh-
bouring glutamate residues appear to direct nitration
to speci¢c tyrosine residues [72]. This emphasises the
point that the local protein environment in£uences
the e⁄ciency of tyrosine modi¢cation, like many oth-
er biochemical mechanisms. (3) Catalysis by metal-
loproteins, such as superoxide dismutase, promotes
nitration of tyrosine and has been suggested to play a
key role in the pathogenesis of motor neurone dis-
ease [73]. Considering these issues, and acknowledg-
ing the fact that additional mechanisms of tyrosine
nitration are viable in vivo, ONOO3 remains one of
the best characterised and plausible of these proc-
esses.
Another important advance in the study of nitra-
tion reactions has been the recent ¢ndings showing
that at sites of neutrophil in¢ltration, other RNS
may result in tyrosine nitration and chlorination
[74]. From a biochemical perspective this is perhaps
not surprising since all that is required to achieve
nitration is the stabilisation of a nitrosonium cation
(NO2 ) donor or a radical termination reaction with
NO2. The fact that this can be achieved so readily in
biological systems took some time to appreciate but
is now widely accepted. In principle, this means that
one of the major metabolites of NO, nitrite (NO32 ),
can be converted to NO2 or NO2 by any compound
which is a suitable one or two electron acceptor re-
spectively (Fig. 3). An interesting example of this is
the reaction of NO32 with hypochlorous acid (HOCl)
which generates NO2 [75^77] via formation of nitryl
chloride (Cl-NO2). In this case both chlorination and
nitration of biological phenolic compounds can oc-
cur [74]. Furthermore, it was demonstrated that
NO32 can be converted into a nitrating agent, pre-
sumably via its reduction to NO2 and/or NO2 , by
myeloperoxidase [78]. Myeloperoxidase is a haem
protein secreted from activated neutrophils, that
uses hydrogen peroxide to produce hypochlorous
acid (HOCl). Other peroxidase enzymes can also cat-
alyse such reactions [79], as illustrated in Fig. 3. Sub-
sequent studies have indeed shown that activated
neutrophils can nitrate model phenolic compounds
as well as tyrosine residues in proteins, and that
this can occur in a NO32 - or ONOO
3-dependent
process [74,79]. These studies clearly suggest that
more than one mechanism of nitrotyrosine formation
may operate in vivo especially at sites of in£amma-
tion.
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6. RNS and cell signalling
Reactive oxygen species and RNS play an essential
role as signalling intermediates. For example, growth
factors, environmental stress, and cytokines regulate
speci¢c cellular responses through redox-sensitive
signalling pathways [80].
What precisely is meant by ‘redox’ modulation of
cell signalling at a molecular level has yet to be
clearly de¢ned. Indications of likely directions for
this area of research have come from studies showing
that NO attenuates in£ammatory responses induced
by cytokines in vascular endothelial and smooth
muscle cells [81,82] and these e¡ects appear to be
regulated through modulation of NFUB activity
[83]. Furthermore, NO was shown to activate the
GTP binding protein p21Ras.
One mechanism by which NO regulates Ras/MAP
kinases and the Ras/NFUB pathway is S-nitrosation
of Cys118 on Ras [84^86]. This was con¢rmed using
site-directed mutagenesis of Cys118 to Ser resulting
in a dominant negative phenotype of Ras, which
when transfected into Jurkat cells completely inhib-
ited NO-dependent activation of MAP kinases [87].
More recently, it was demonstrated that NO stimu-
lates haem oxygenase induction, through mecha-
nisms involving both ONOO3 formation and reac-
tion with intracellular thiols [88]. These data are
consistent with S-nitrosation of cysteine residues act-
ing as a pivotal switch to directly modulate enzymes
in signalling cascades or ion channels [86,89].
Indirect e¡ects on cellular signalling pathways by
RNS could also be mediated by tyrosine nitration.
Indeed nitration of tyrosine by ONOO3 results in an
inhibition of tyrosine phosphorylation [90,91] and
appears to target the modi¢ed proteins for degrada-
tion [90]. Since numerous signalling pathways depend
on tyrosine phosphorylation, nitration reactions rep-
resent an important interface between formation of
RNS and cell function. Alternatively, nitration of
certain proteins, such as glutamine synthetase, can
alter protein function and thus compromise their bio-
logical role [91]. Also other studies have demon-
strated that nitration of tyrosines is associated with
irreversible inhibition of enzyme function [61]. An-
other important example of tyrosine nitration leading
to the inactivation of an enzyme that could be im-
plicated in cells signalling is the nitration of the mi-
tochondrial Mn superoxide dismutase [92]. This was
shown to occur during rejection of kidneys and since
the enzyme is situated in the mitochondrial matrix
is likely to be an ONOO3-dependent process.
Although it has received less attention, nitration of
tryptophan also occurs on reaction with RNS, and
could similarly e¡ect electron transfer proteins [93].
7. Peroxynitrite and apoptosis
Interactions with signalling molecules may e¡ect
the outcome of important biological processes such
as apoptosis. Apoptosis is an evolutionarily con-
served, genetically controlled process and is an im-
portant event during development and homeostasis.
Disruption in the regulation of apoptosis is thought
Fig. 3. Peroxidase dependent mechanisms of nitration. Mecha-
nisms of nitration which do not involve ONOO3 include perox-
idase mediated oxidation of nitrite (NO32 ) to either nitrogen
dioxide radical (NO2) or nitronium cation (NO2 ). Myelo-
peroxidase is a mammalian peroxidase, which has been shown
to mediate nitration of phenolics utilising NO32 as a reducing
substrate as outlined in the ¢gure. The ¢rst step (step 1) in-
volves a two electron process by which the resting state of the
enzyme (i.e. a ferric haem, FeIII) is oxidised to compound I (i.e.
the ferryl oxidation state with an associated protein or porphyr-
in radical, Xc-FeIV = O). Compound I can be reduced to com-
pound II (i.e. ferryl haem, FeIV = O) by NO32 forming NO2
(step 2). In turn compound II can be reduced back to the
ground state of the enzyme by NO2 yielding NO2 (step 3). Al-
ternatively, NO32 may be formed by a two electron reduction
of compound I directly to the ferric form (step 4). Both NO2
and NO32 can nitrate phenolic compounds through radical ter-
mination or electrophilic substitution reactions respectively. It
should be noted that NO32 may also react with compound II
and NO2 with compound I.
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to play a key role in the development of numerous
diseases [94^96]. Apoptotic cell death is characterised
by the appearance of certain morphological altera-
tions to cells such as membrane blebbing, chromatin
condensation, DNA fragmentation and cell shrink-
age [97]. The process leads to an orderly breakup
of the cell contents forming apoptotic bodies, which
are then phagocytosed by other cells [98]. Apoptosis
can be initiated by a variety of stimuli, both physio-
logical and non-physiological. These stimuli activate
signalling pathways, most of which converge at a
series of caspase enzymes [98,99] which catalyse the
cleavage of the nuclear lamina component, lamin A,
or the DNA repair enzyme poly(ADP) ribose poly-
merase (PARP) [100^102]. The cleavage of PARP by
caspases, particularly caspase 3, leads to failure in
the repair of DNA damage and ultimately to apop-
tosis.
Peroxynitrite has been reported to induce DNA
damage and apoptosis in a variety of cell types
such as thymocytes, cortical cells and HL-60 leukae-
mia cells [103^105]. Similar concentrations of
ONOO3 to those added to the HL-60 cells did not
induce apoptosis in either endothelial cells or blood
cells suggesting that these have a more e⁄cient de-
fence system against ONOO3 mediated damage than
leukaemia cells [106]. The mechanism by which
ONOO3 induces apoptosis is unclear although sub-
sequent formation of reactive oxygen species has
been suggested [107].
Other mechanisms of cellular injury include an
ONOO3-dependent increase in DNA strand break-
age, which triggers the activation of PARP. This en-
zyme ADP-ribosylates proteins and then extends the
ADP ribose group into a nucleic acid like polymers,
in the process depleting the cell of NAD. Eventu-
ally the depletion of cellular NAD results in mito-
chondrial dysfunction and necrotic cell death [108].
Such changes have been observed in activated mac-
rophages, which have been shown to produce
ONOO3 [108]. A decrease in the NAD content of
the macrophage, which could be inhibited with the
PARP inhibitor 3-aminobenzamide, and inhibition
of mitochondrial respiration also occurred after mac-
rophage activation [108]. Peroxynitrite induced
PARP activation was demonstrated in vascular
smooth muscle cells and was associated with a sup-
pression of aortic contractility. This observation sug-
gests that ONOO3 induced PARP activation may
contribute to a loss of vascular function in condi-
tions such as septic shock [109].
Peroxynitrite-induced apoptosis can be in£uenced
either positively or negatively by the presence of
growth factors. Pretreatment of ¢broblast cells with
¢broblast growth factor (FGF-1) augmented the
amount of apoptosis induced by ONOO3, but has
no e¡ect on programmed cell death induced by other
reactive oxygen species [110]. The mechanism of this
enhanced apoptotic e¡ect is unclear but seems to
involve an increase in the amount of tyrosine nitra-
tion. In contrast pretreatment of PC12 pheochromo-
cytoma cells with nerve growth factor (NGF) pro-
tected these cells against ONOO3-induced apop-
tosis via a phosphatidylinositol-3-kinase-dependent
pathway [73,111]. Some of the ¢rst evidence con-
sistent with ONOO3-induced apoptosis in a cellular
setting has recently been obtained in motor neurones
and is thought to be relevant to amylotrophic lateral
sclerosis [112].
A number of pathological conditions that have an
in£ammatory component have been suggested to
progress through ONOO3-induced apoptosis. These
conditions include bacterial infections, the onset of
insulin-dependent diabetes mellitus (IDDM) and a
number of neurodegenerative diseases.
Infection of the digestive tract by Helicobacter py-
lori leads to in£ammatory bowel disease, a risk factor
for gastric cancer [113]. Infection of gastric epithelial
cells with H. pylori leads to iNOS activation, forma-
tion of ONOO3 and is associated with an increase in
DNA fragmentation and apoptosis [114]. Protection
against ONOO3 mediated cell death may be a¡orded
by antioxidants such as ascorbic acid. For example
ascorbate prevented ONOO3-induced apoptosis in
human intestinal epithelial cells either when added
before or concurrently with ONOO3 [115]. Various
models of insulin-dependent diabetes mellitus have
shown that the loss of L islet cells occurs by apop-
tosis mediated by ONOO3 formed by in¢ltrating im-
mune cells [116^123]. The level of the cellular anti-
oxidant glutathione seems to be a critical factor
in neuronal susceptibility to peroxynitrite-induced
apoptosis, with high levels of glutathione being pro-
tective [124].
In certain circumstances the production of
ONOO3 may in fact be bene¢cial, for instance, in-
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duction of ONOO3 formation in tumour cells can
lead to elimination of the disease. The anti-tumour
agent £avone acetic acid has been shown to stimulate
ONOO3 production in subcutaneous mouse tumours
via the induction of iNOS. This ONOO3 production
correlated with the presence of apoptosis in the tu-
mour and led to its dissolution [125].
8. Reactions of RNS to yield NO donors
From Fig. 1 it might be anticipated that RNS,
through a combination of oxidative and nitrosative
stress, would inhibit normal NO-dependent func-
tions. However, in the intensive investigations of
the e¡ects of ONOO3 in biological systems it was
demonstrated that ONOO3 possesses physiological
properties, which are similar to those of NO
[17,18,126^132]. These include the induction of blood
vessel relaxation and the inhibition of platelet aggre-
gation and leucocyte adhesion to the endothelium
[17,133].
These NO-‘like’ e¡ects of ONOO3 occur through
an NO-dependent mechanism since scavengers of
NO or inhibitors of guanylate cyclase abolish this
response in both platelets and artery ring segments
[128]. In vivo, systemic administration of ONOO3
transiently reduces mean arterial pressure in rats con-
sistent with NO release [134]. With repeated admin-
istration, however, tachyphylaxis rapidly ensued, and
the blood pressure lowering e¡ect of ONOO3 was
lost. This e¡ect was also found on exposure of iso-
lated perfused hearts to ONOO3, and is similar to
the development of nitrate ‘tolerance’ after chronic
usage of organic nitrates such as nitroglycerin
[126,136].
There are two potential sources for the formation
of compounds with NO-donating properties. The
¢rst of these is the reaction of ONOO3 with poly-
hydroxylated compounds such as glucose and glycer-
ol, resulting in the incorporation of NO-containing
groups in these molecules [127,137]. The second is
the reaction with either low molecular weight or pro-
tein bound thiols [17,18,59]. Either of these reaction
products are moderately stable species, capable of
releasing NO on contact with tissues, resulting in
NO-dependent vasodilatation and inhibition of pla-
telet aggregation [17,133]. Peroxynitrite can also in-
duce the formation of NO donors via reactions with
membrane impermeant sugars such as mannitol
[17,132]. The vasorelaxant activity associated with
these compounds may be due, in part, to the sponta-
neous release of low quantities of NO or the reduc-
tive metabolism at the cell surface.
Detailed structural analysis of the reaction prod-
ucts of glycerol and ONOO3 revealed the formation
of both glyceryl mononitrate and mononitrite, me-
tabolites of nitroglycerin [137]. These products are
formed at su⁄cient concentrations to exert biological
e¡ects such as vessel relaxation. Treatment of arterial
tissues with diethyl maleate, an agent that depletes
tissue thiol groups, also blunts the relaxant e¡ects of
ONOO3. This result was interpreted as evidence for
ONOO3-dependent nitrosation of cellular sulphydryl
groups, yielding a nitrosothiol compound, which can
be further metabolised to release free NO [128].
However, it is also consistent with the formation of
an S-nitrosothiol from an organic nitrite derived
from the reaction between ONOO3 and glucose
(Fig. 4). The vasorelaxant responses to ONOO3
Fig. 4. Mechanisms underlying the vasorelaxant e¡ect of perox-
ynitrite. Under conditions of vascular stress such as hypercho-
lesterolaemia, NO is prevented from direct activation of guany-
late cyclase (GC) due to its reaction with O32 . However,
ONOO3 can modify thiol-containing proteins (RSH) or polyhy-
droxylated compounds such as glucose (ROH), resulting in the
formation of NO donors. The reaction product of glucose and
ONOO3 is structurally and biochemically related to the organic
nitrites (RONO). RONO may be further modi¢ed to form an
S-nitrosothiol (RSNO) which is metabolised intracellularly to
release free NO, resulting in activation of GC [135]. Elevations
in cGMP are associated with a reduction in intracellular calci-
um and vessel relaxation. Peroxynitrite may also induce relaxa-
tion via the activation of ATP-sensitive potassium channels in
the VSMC membrane. Potassium e¥ux through this channel is
associated with membrane hyperpolarisation and a decrease in
vascular excitability.
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were similar in both intact and endothelium-denuded
canine coronary arteries, suggesting a direct action of
an NO-donating metabolite at the level of the vas-
cular smooth muscle cell (VSMC) [129]. It is clear
that the nitrosative reactions resulting in the forma-
tion of NO donors may occur with a high chemical
yield in biological systems where NO and O32 are
generated simultaneously [59]. This is evident in the
treatment of platelets in which the inhibition of pla-
telet aggregation by ONOO3 occurs before oxidation
reactions can be detected [17,133]. This no doubt
arises because of the exquisite sensitivity of biological
systems to NO-dependent e¡ects. This may be par-
ticularly important in an in£ammatory setting where
it is likely that NO is inactivated by O32 . The NO
donors react much less readily with O32 than NO
thus preserving NO-dependent signalling pathways
under conditions where they would otherwise be in-
active.
It is critical that appropriate control experiments
are performed when studying the vascular e¡ects of
ONOO-derived NO donors in vitro. This is under-
scored by ¢ndings of a recent study which suggest
that ONOO3 readily reacts with HEPES, a common
component of bu¡ers used in vessel reactivity studies,
to form an NO donating metabolite [138]. Topical
application of ONOO3 relaxes cerebral vessels by a
mechanism that is insensitive to blockade by a gua-
nylate cyclase inhibitor [139]. This response was pre-
vented by glyburide, a speci¢c blocker of the ATP-
sensitive potassium channel (IKATP). It was sug-
gested that ONOO3 directly activates IKATP in vas-
cular smooth muscle cells of cerebral arteries, result-
ing in membrane hyperpolarisation and vessel
relaxation [139].
Taken together these data suggest that, while oxi-
dation is likely the primary reaction mechanism of
ONOO3, nitration and nitrosation of proteins, car-
bohydrates and thiols result in the formation of com-
pounds which act as NO donors. Reaction pathways
involved in NO donor formation are summarised in
Fig. 4.
9. Summary
It is well recognised that NO has an important role
in many physiological processes and we propose that
this be extended to include the generation of a range
of RNS. These compounds have two e¡ects in bio-
logical systems. The ¢rst of these is to e¡ectively
remove NO-dependent responses, a fact that has
been well appreciated in our understanding of vascu-
lar disease such as atherosclerosis. The second is to
generate novel compounds which have distinct sig-
nalling properties which may either duplicate those
of NO or antagonise them. Although this makes the
investigation of the e¡ects of RNS in biological sys-
tems yet more complex, it does emphasise the need to
complement a biochemical approach with experi-
ments in which functional parameters are also meas-
ured.
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